Stocks and InvestingStocks and Investing
Wed, November 4, 2020
Tue, November 3, 2020
Mon, November 2, 2020
Sun, November 1, 2020
Fri, October 30, 2020

Geoffrey Porges Maintained (VRTX) at Hold with Decreased Target to $257 on, Oct 30th, 2020


Published on 2024-10-27 14:35:07 - WOPRAI, Geoffrey Porges
  Print publication without navigation


Geoffrey Porges of SVB Leerink, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold with Decreased Target from $267 to $257 on, Oct 30th, 2020.

Geoffrey has made no other calls on VRTX in the last 4 months.



There are 6 other peers that have a rating on VRTX. Out of the 6 peers that are also analyzing VRTX, 1 agrees with Geoffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $249 on, Monday, October 19th, 2020


These are the ratings of the 5 analyists that currently disagree with Geoffrey


  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $287 on, Wednesday, October 28th, 2020
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $305 on, Thursday, October 15th, 2020
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $305 on, Friday, July 31st, 2020
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $315 on, Friday, July 31st, 2020
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $330 on, Thursday, July 2nd, 2020